A wide variety of proteins in neuronal, endocrine and immune tissues undergo proteolytic processing. Many of these proteins and peptides are intercellular messengers. Most neuroendocrine peptides are synthesized from precursor proteins. Post-translational processing of these precursors is a key step in the production of biologically active peptides. In the majority of cases this occurs by proteolysis of the precursors at 'classical'cleavage sites involving endopeptidases of the subtilisin family. A subset of bioactive peptides are generated by processing at 'non-classical'cleavage sites;the protease(s) responsible for these cleavages have not been well explored. Members of the metalloendoprotease family are thought to be involved in non- classical processing. Among them, endothelin converting enzyme-2 (ECE-2) is a good candidate since it exhibits functional properties that are consistent with it being a neuropeptide biosynthetic enzyme. In this grant application we propose to examine the hypothesis that "ECE-2 is neuropeptide processing enzyme that generates novel bioactive peptides by non-classical processing".
The specific aims are, (i) to characterize the biochemical and enzymological properties of ECE-2, (ii) to study the behavioral phenotype of animals lacking ECE-2 including addictive behaviors, and (iii) to examine the peptide profile in mice lacking ECE-2 using differential isotopic labeling and mass spectrometry. These studies are synergistic and will expand our current knowledge of neuropeptide processing by providing information about novel neuropeptides. Furthermore, findings from these studies will form a basis for future research exploring the functions of these novel neuropeptides in vivo. Since a variety of neuropeptides are involved in normal functioning of the brain, understanding the mechanisms that regulate their endogenous levels becomes a prerequisite to the development of strategies for the treatment of a variety of pathologies including neurodegenerative disorders and drug addiction.

Public Health Relevance

This proposal describes studies on endothelin converting enzyme-2 - a peptide processing enzyme shown to be involved in a number of disorders including drug addiction and Alzheimer's disease. The findings from the proposed studies would help in the development of novel therapeutics for the treatment of these and other neuroendocrine disorders.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Molecular Neuropharmacology and Signaling Study Section (MNPS)
Program Officer
Gnadt, James W
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
Schools of Medicine
New York
United States
Zip Code
Gupta, Achla; Gomes, Ivone; Wardman, Jonathan et al. (2014) Opioid receptor function is regulated by post-endocytic peptide processing. J Biol Chem 289:19613-26
Toniolo, Elaine F; Maique, Estêfani T; Ferreira Jr, Wilson A et al. (2014) Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. Peptides 56:125-31
Yang, Lili; Rozenfeld, Raphael; Wu, Defeng et al. (2014) Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med 68:260-7
Narita, Minoru; Imai, Satoshi; Nakamura, Atsushi et al. (2013) Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state. Addict Biol 18:614-22
Hipser, Chris; Bushlin, Ittai; Gupta, Achla et al. (2010) Role of antibodies in developing drugs that target G-protein-coupled receptor dimers. Mt Sinai J Med 77:374-80
Abul-Husn, Noura S; Bushlin, Ittai; Moron, Jose A et al. (2009) Systems approach to explore components and interactions in the presynapse. Proteomics 9:3303-15
Gagnidze, Khatuna; Sachchidanand; Rozenfeld, Raphael et al. (2008) Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2. J Med Chem 51:3378-87
Rodriguiz, R M; Gadnidze, K; Ragnauth, A et al. (2007) Animals lacking endothelin-converting enzyme-2 are deficient in learning and memory. Genes Brain Behav :
Mzhavia, Nino; Qian, Yimei; Feng, Yun et al. (2002) Processing of proSAAS in neuroendocrine cell lines. Biochem J 361:67-76
Che, F Y; Yan, L; Li, H et al. (2001) Identification of peptides from brain and pituitary of Cpe(fat)/Cpe(fat) mice. Proc Natl Acad Sci U S A 98:9971-6

Showing the most recent 10 out of 13 publications